Literature DB >> 1346247

High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase.

K Schmidt1, P Klatt, W F Graier, G M Kostner, W R Kukovetz.   

Abstract

Oxidatively modified LDL (LDLox) reduces the response of soluble guanylyl cyclase to nitrovasodilators. We now demonstrate that this desensitization can be antagonized by HDL. Similar to its protective effect against LDLox, HDL also inhibited the lysolecithin-induced desensitization of soluble guanylyl cyclase. Since the lysolecithin content of LDLox correlated with the amount of lysolecithin necessary to diminish stimulation of soluble guanylyl cyclase, our data support the hypothesis that lysolecithin may be responsible for the inhibitory effect of LDLox on smooth muscle relaxation and provide evidence that the antagonistic effect of HDL against desensitization of soluble guanylyl cyclase by atherogenic compounds could be responsible for the protective role of HDL in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346247     DOI: 10.1016/s0006-291x(05)80145-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.

Authors:  G Murugesan; P L Fox
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

2.  Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis.

Authors:  Volker O Melichar; Delphine Behr-Roussel; Ulrike Zabel; L Otto Uttenthal; José Rodrigo; Alain Rupin; Tony J Verbeuren; Arun Kumar H S; Harald H H W Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

3.  Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study.

Authors:  Ursula Schwab; Tuulikki Seppänen-Laakso; Laxman Yetukuri; Jyrki Agren; Marjukka Kolehmainen; David E Laaksonen; Anna-Liisa Ruskeepää; Helena Gylling; Matti Uusitupa; Matej Oresic
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.